Pfizer has begun testing an omicron vaccine, it remains unknown when will be completely ready for use

USA – Pfizer and Biontec have begun clinical trials of a coronavirus ion micron strain vaccine.

The study will assess the safety, tolerability and level of the immune response, and more than 1,400 people are involved in the study.

– Although existing research and data show that booster doses of the vaccine continue to provide a high level of protection against severe disease and hospitalization, we have recognized the need for a new vaccine in case this protection weakens over time and potentially helps “Solving problems caused by omicron or possible new strains in the future,” said a statement from Pfizer, a senior vice president and head of vaccine research and development.

The vaccine specifically made against the omicron strain will be given in a dose of 30 micrograms, just like the current vaccine.

Related Articles

Back to top button